| Institution: | 1. Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India;2. Department of Biostatistics, Advanced Centre for Treatment, Research and Education in Cancer, Homi Bhabha National Institute, Navi Mumbai, India;1. Department of Respiratory Medicine, Cellular Transplantation Biology, Graduate School of Medicine, Kanazawa University, 13-1, Takara-machi, Kanazawa 920-8641, Japan;2. National Hospital Organization, Nanao Hospital, 3-1, Matto-machi, Nanao 926-8531, Japan;1. Winship Cancer Institute of Emory University, Atlanta, Georgia;2. Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts;3. KU Leuven, Universitaire Ziekenhuizen, Leuven, Belgium;4. Hetenyi G Korhaz, Szolnok, Hungary;5. Orszagos Koranyi TBC es Pulmonologiai Intezet, Budapest, Hungary;6. Tudogyogyintezet Torokbalint, Torokbalint, Hungary;7. University of Washington Seattle Cancer Care Alliance, Seattle, Washington;8. University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada;9. CHI de Créteil, Créteil, France;10. Hospital Universitario Virgen del Rocio, Seville, Spain;11. Fakultni Nemocnice Olomouc, Olomouc, Czech Republic;12. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain;13. Fakultni Nemocnice Ostrava, Ostrava Poruba, Czech Republic;14. Lynn Cancer Institute/Boca Raton Regional Hospital, Boca Raton, Florida;15. Yale University School of Medicine, New Haven, Connecticut;p. Université de Sherbrooke, Centre intégré de cancérologie de la Montéregie, Hôpital Charles Le Moyne, Greenfield Park, Quebec City, Canada;q. Penn State Cancer Institute, Hershey, Pennsylvania;r. H. Lee Moffitt Cancer Center, Tampa, Florida;s. Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, Florida;t. Tudogyogyintezet Torokbalint, Törökbálint, Hungary;u. University of Texas M. D. Anderson Cancer Center, Houston, Texas;v. Personal Genome Diagnostics, Baltimore, Maryland;1. Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark;2. Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark;3. Department of Internal Medicine, Section of Respiratory Medicine, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark;4. Department of Clinical Biochemistry, Zealand University Hospital, Køge, Denmark;5. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;6. Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark;1. Division of Infection Immunity and Respiratory Medicine, University of Manchester, Manchester, England;2. Manchester University NHS Foundation Trust, Manchester, England;3. Artemida Pharma Ltd, Stevenage, England;4. North Manchester General Hospital, Pennine Acute NHS Trust, Manchester, England;5. Division of Respirology, Department of Medicine, McMaster University, Hamilton, ON, Canada;6. Idfac Ltd, Devon, England;7. NeRRe Therapeutics Ltd, Stevenage, England;1. Department of Radiation Oncology, Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Australia;2. School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdon;3. Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia;4. Health and Biomedical Informatics Centre, The University of Melbourne, Melbourne, Australia;6. Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia;5. Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia;7. Alfred Health Radiation Oncology Services, Prahran, Australia;11. Central Clinical School, Monash University, Melbourne, Australia |
